| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 05/02/2007 | EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 05/02/2007 | CN1957019A Deuterated polyimides and derivatives thereof |
| 05/02/2007 | CN1956975A Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity |
| 05/02/2007 | CN1956955A Neurogenic pain control agent composition |
| 05/02/2007 | CN1956954A Novel androgens |
| 05/02/2007 | CN1956949A Substituted sulfonamides |
| 05/02/2007 | CN1955183A 20-bit esterified camptothecine derivate, its preparation method and drug composite and use |
| 05/02/2007 | CN1955172A Phthalic acid derivative and use for preparing phthalamide derivative intermediate |
| 05/02/2007 | CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/02/2007 | CN1955163A Cyclooxygenase-2 selection inhibitor and its medicine use |
| 05/02/2007 | CN1955162A Phthalic acid derivative and use for preparing phthalamide derivative intermediate |
| 05/01/2007 | US7211694 Substituted 4-aminocyclohexanols |
| 05/01/2007 | US7211632 excellent mechanical, thermal and optical properties, in the preparation of organic materials for high-power lasers used in particular when nuclear physics experiments are carried out; comprising, for example, d6-3,3',4,4'-biphenyltetracarboxylic dianhydride and d8-p-phenylenediamine |
| 05/01/2007 | US7211600 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 05/01/2007 | CA2189524C Aminomethyl-2,3,8,9-tetrahydro-7h-1,4-dioxino-[2,3e]indol-8-ones and derivatives |
| 05/01/2007 | CA2143636C Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
| 04/26/2007 | WO2007047837A2 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders |
| 04/26/2007 | WO2007047306A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 04/26/2007 | WO2007047177A1 Acyl indoles, compositions containing such compounds and methods of use |
| 04/26/2007 | WO2007046486A1 Aromatic amine compound, and light emitting element, light emitting device, and electronic device using aromatic amine compound |
| 04/26/2007 | WO2007046112A1 Arylthioether tryptamine derivatives as functional 5-ht6 ligands |
| 04/26/2007 | WO2007046111A1 Carbazole derivatives as functional 5-ht6 ligands |
| 04/26/2007 | WO2007046075A1 Piperazine derivatives as antimalarial agents |
| 04/26/2007 | WO2007045867A1 3 -aminoindole compounds as crth2 receptor ligands |
| 04/26/2007 | WO2007014839A3 Cathepsin k inhibitors |
| 04/26/2007 | WO2006136606A3 Oxindole derivatives |
| 04/26/2007 | WO2006131833A3 New hybrid oligomers. their preparation process and pharmaceutical compositions containing them |
| 04/26/2007 | WO2006097809A3 Novel tyrosine derivatives |
| 04/26/2007 | WO2005112921A3 Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity |
| 04/26/2007 | WO2005087728A9 Resistance-repellent retroviral protease inhibitors |
| 04/26/2007 | US20070093663 Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof. |
| 04/26/2007 | US20070093531 Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them |
| 04/26/2007 | US20070093530 Substituted indolealkanoic acids |
| 04/26/2007 | US20070093505 2,3-Substituted 5,6-diaryl-pyrazine derivatives as cb1 modulators |
| 04/26/2007 | US20070093476 Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/26/2007 | US20070093430 Interferons; polyoxyethylene glycol |
| 04/26/2007 | US20070092441 Fluoridation method |
| 04/26/2007 | CA2624904A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 04/26/2007 | CA2624007A1 Acyl indoles, compositions containing such compounds and methods of use |
| 04/26/2007 | CA2623213A1 Piperazine derivatives as antimalarial agents |
| 04/25/2007 | EP1777214A2 Novel aryloxy-alkyl-dialkylamines |
| 04/25/2007 | EP1776340A1 N-(1h-indolyl)-h-indole-2-carb0xamide derivatives, their preparation and their therapeutic use |
| 04/25/2007 | EP1776339A2 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
| 04/25/2007 | EP1776338A1 Indole, indazole or indoline derivatives |
| 04/25/2007 | EP1631533A4 Novel process for stereoselective reduction of beta-ketoesters |
| 04/25/2007 | EP1326623B1 Saururus chinensis extract for prevention and treatment of neurodegenerative disease |
| 04/25/2007 | EP1100780B1 2,3,3a,4,9,9a-HEXAHYDRO-8-HYDROXY-1H-BENZ[F]INDOLES, A METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE AS MEDICAMENTS |
| 04/25/2007 | EP1047645B8 Compound for use as a mineral fibre binder and process for providing such |
| 04/25/2007 | CN1953967A Purification of progesterone receptor modulators |
| 04/25/2007 | CN1953964A Resistance-repellent retroviral protease inhibitors |
| 04/25/2007 | CN1953963A Process for producing cyclic N-hydroxyimide compound |
| 04/25/2007 | CN1953747A Diphenyl-indol-2-on compounds and their use in the treatment of cancer |
| 04/25/2007 | CN1312155C Method for separating and purifying 9-nitro camptothecin |
| 04/25/2007 | CN1312128C Method for preparing 13 5-triaminobenzene and hydrolyzing it into high-purity phloroglucinal |
| 04/24/2007 | USRE39590 3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-6-trifluoromethyl-2,4(1H, 3H)-pyrimidinedione; useful for general or pre-emergent or post-emergent control of undesired plant species and defoliants at very low concentrations |
| 04/24/2007 | US7208623 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives |
| 04/24/2007 | US7208607 Reaction of 2-bromophenylalaninate with diisopropylethylamine and (2R)-2-bromopropionyl chloride and reaction of product with ethyl (2S)-2-aminopentanoate, triethylamine and acetonitrile, and hydrogenation of product; new process uses readily obtainable starting materials |
| 04/24/2007 | US7208516 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor |
| 04/24/2007 | US7208505 Treating Type 2 diabetes and/or obesity; compounds are indoles substituted at position 3 with a (3-(2-(heterocycle-substituted)phenoxy)-2-hydroxypropylamino)alkyl group |
| 04/24/2007 | US7208493 Vasculostatic agents and methods of use thereof |
| 04/24/2007 | US7208491 N-monoacylated o-phenylenediamines |
| 04/24/2007 | CA2403902C Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 04/19/2007 | WO2007043835A1 Fab i inhibitor and process for preparing same |
| 04/19/2007 | WO2007043484A1 Carbazole-containing amine compound and use thereof |
| 04/19/2007 | WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043371A1 Stilbene derivatives, light-emitting element and light-emitting device |
| 04/19/2007 | WO2007043354A1 Spirofluorene derivative, material for light-emitting element, light-emitting element, light-emitting device, and electronic device |
| 04/19/2007 | WO2007042912A2 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 04/19/2007 | WO2007017546A3 Method of obtaining tryptamine derivatives |
| 04/19/2007 | WO2007005887A3 Androgen receptor modulator compounds, compositions and uses thereof |
| 04/19/2007 | WO2007000339A8 Bicyclic derivatives as p38 kinase inhibitors |
| 04/19/2007 | WO2007000337A8 Bicyclic derivatives as p38 kinase inhibitors |
| 04/19/2007 | WO2006034317A3 Chemical compounds |
| 04/19/2007 | US20070088168 Reaction of benzyl (2S)-2,3,4,5,6,7-hexahydro-1H-indole-2-carboxylate with triethylamine and then (2S)-2-[(tert-butoxycarbonyl)amino]propionyl chloride and reaction of product with ethyl 2-oxopentanoate and hydrogenation using platinum on carbon catalyst |
| 04/19/2007 | US20070088073 Method for treating pain |
| 04/19/2007 | US20070088071 3-[(3-Bromo-4-{(2S)-2-[(5-chloro-1-methyl-1H-indol-2-yl)carbonyl]heptyl}benzoyl)amino]propanoic acid and 3-[(3-Bromo-4-{(2R)-2-[(5-chloro-1-methyl-1H-indol-2-yl)carbonyl]heptyl}benzoyl)amino]propanoic acid; glucagon receptor antagonists; type 2 diabetes mellitus |
| 04/19/2007 | US20070088068 E-series of prostaglandin (EP) receptors; reducing [4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetate to form [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 04/19/2007 | US20070088018 Cb1 antagonist compounds |
| 04/19/2007 | US20070085074 Merocyanine dye and use thereof |
| 04/19/2007 | CA2625962A1 Fab i inhibitor and process for preparing same |
| 04/19/2007 | CA2625219A1 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 04/19/2007 | CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/18/2007 | EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 04/18/2007 | EP1773814A2 Substituted oxindol derivatives and medicaments containing the same |
| 04/18/2007 | EP1773807A2 Kinase inhibitors |
| 04/18/2007 | EP1773780A2 Amido compounds and their use as pharmaceuticals |
| 04/18/2007 | EP1773771A2 Compounds and methods for treatment of thrombosis |
| 04/18/2007 | EP1773770A1 Indole-2-carboxamidine derivatives as nmda receptor antagonists |
| 04/18/2007 | EP1773756A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 04/18/2007 | EP1773754A2 Methods and compositions for treating cancer |
| 04/18/2007 | EP1773404A2 Methylamine risks and treatment with n-derivatives of hyperactivity, depression and alcoholism |
| 04/18/2007 | EP1773398A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 04/18/2007 | EP1773348A2 Tetrapeptide analogs |
| 04/18/2007 | EP1453792B1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease |
| 04/18/2007 | EP1353673B1 Camptothecin derivatives |
| 04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/18/2007 | EP1028940B1 Process to produce oxazolidinones |
| 04/18/2007 | CN1950393A Novel inhibitors of hepatitis c virus ns3 protease |
| 04/18/2007 | CN1950365A Indolyl derivatives as liver-X-receptor modulators |